Screening and chemoprevention in lung cancer
Clin. transl. oncol. (Print)
; 10(5): 274-280, mayo 2008.
Article
in English
| IBECS
| ID: ibc-123447
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
Lung cancer is a major health problem due to its incidence and mortality. The risk factors, the existence of a preclinical phase, and the relationship between stage at diagnosis and survival are known. A number of strategies that aim to diagnose lung cancer in its earliest stages, based principally on imaging studies, are therefore being tested. Several drugs aimed at reducing the probability of developing lung cancer in the at-risk population are also under study. At the present time, the results obtained have not been encouraging and we do not have a clear strategy either for early diagnosis or for the use of chemopreventive agents (AU)
RESUMEN
No disponible
Search on Google
Collection:
National databases
/
Spain
Health context:
SDG3 - Health and Well-Being
/
SDG3 - Target 3.4 Reduce premature mortality due to noncommunicable diseases
Health problem:
Target 3.4: Reduce premature mortality due to noncommunicable diseases
/
Other Respiratory Diseases
/
Trachea, Bronchus, Lung Cancers
Database:
IBECS
Main subject:
Mass Screening
/
Clinical Trials as Topic
/
Chemoprevention
/
Lung Neoplasms
Type of study:
Diagnostic study
/
Prognostic study
/
Risk factors
/
Screening study
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2008
Document type:
Article
Institution/Affiliation country:
Arnau de Vilanova Hospital/Spain
/
Asturias Central University Hospital/Spain
/
Hospital General Universitario Marina Alta/Spain
